Evidence map›Paper›PMID 26366180›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2015

Intravenous Injections of Human Mesenchymal Stromal Cells Modulated the Redox State in a Rat Model of Radiation Myelopathy.

Jing Zhang, Lian-Bing Li, Zhu Qiu, Hong-Bo Ren, Jia-Yan Wu, Tao Wang, Zhong-Hui Bao, Ji-Fan Yang, Ke Zheng, Shao-Lin Li and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Jing ZhangThe First Affiliated Hospital of Liaoning Medical University, No. 2 Renmin Street, Guta District, Jinzhou, Liaoning 121000, China.
Lian-Bing LiKey Laboratory of Birth Defects and Reproductive Health of The National Health and Family Planning Commission, Chongqing Population and The Family Planning Science and Technology Research Institute, Chongqing 400020, China.
Zhu QiuMolecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Hong-Bo RenDepartment of Oncology, The Second People's Hospital of Banan, Chongqing 400054, China.
Jia-Yan WuDepartment of Obstetrics and Gynecology, Xinqiao Hospital, The Third Military Medical University, Chongqing 400038, China.
Tao WangDepartment of Orthopedics II, Xi'An Gao Xin Hospital, Xi'an 710075, China.
Zhong-Hui BaoDepartment of Oncology, The Second People's Hospital of Banan, Chongqing 400054, China.
Ji-Fan YangDepartment of Oncology, The Second People's Hospital of Banan, Chongqing 400054, China.
Ke ZhengMolecular Oncology and Epigenetics Laboratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Shao-Lin LiDepartment of Radiation Medicine, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Li WeiKey Laboratory of Birth Defects and Reproductive Health of The National Health and Family Planning Commission, Chongqing Population and The Family Planning Science and Technology Research Institute, Chongqing 400020, China.
Hua YouAffiliated Hospital of The Academy of Military Medical Sciences, Beijing 100071, China.
Xian Yang Central Hospital · CNChongqing Medical University · CNAcademy of Military Medical Sciences · CNChongqing Population and Family Planning Science and Technology Research Institute · CNFirst Affiliated Hospital of Chongqing Medical University · CNFirst Affiliated Hospital of Liaoning Medical University · CNFirst Hospital of Xi'an · CNNational Health and Family Planning Commission · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main aim of the present study was to assess the antioxidative effects of human umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in a rat model of radiation myelopathy. UC-MSCs were isolated from Wharton's jelly (WJ) of umbilical cords. An irradiated cervical spinal cord rat model (C2-T2 segment) was generated using a (60)Co irradiator to deliver 30 Gy of radiation. UC-MSCs were injected through the tail vein at 90 days, 97 days, 104 days, and 111 days after-irradiation. Histological damage was examined by cresyl violet/Nissl staining. The activities of two antioxidant enzymes catalase (CAT) and glutathione peroxidase (GPX) in the spinal cord were measured by the biomedical assay. In addition, the levels of vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) in the spinal cord were determined by ELISA methods. Multiple injections of UC-MSCs through the tail vein ameliorated neuronal damage in the spinal cord, increased the activities of the antioxidant enzymes CAT and GPX, and increased the levels of VEGF and Ang-2 in the spinal cord. Our results suggest that multiple injections of UC-MSCs via the tail vein in the rat model of radiation myelopathy could significantly improve the antioxidative microenvironment in vivo.

Identifiers

PMID26366180
PMCPMC4561091
OpenAlexW1928730024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.